A prospective randomized split-mouth study of soft tissue augmentation with and without acellular dermal matrix after iliac onlay grafts in atrophied edentulous patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025164

Enrollment

Registered

2021-04-27

Start date

2021-04-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.2

Interventions

Group 1: soft tissue Augmentation on the one site of the jaw with acellular dermal Matrix Group 2: on the other site without soft tissue augmentation

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: extreme alveolar atrophy

Exclusion criteria

Exclusion criteria: radiatio, chemotherapy

Design outcomes

Primary

Measure	Time frame
3 months postoperative after implant Insertion the thickness of the soft tissue will be measured	—

Secondary

Measure	Time frame
12 months postoperative after implant Insertion the thickness of the soft tissue will be measured	—

Countries

Germany

Contacts

Public ContactSusanne Nahles

Charité CVKKlinik für MKG-Chirurgie

susanne.nahles@charite.de030450555022

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026